A new study from researchers led by Johns Hopkins Medicine reports substantial new evidence that elevated blood biomarkers of ...

Want to give your heart a little TLC? Across the country, nearly half of all adults have some form of cardiovascular disease, the leading cause of death for American men and women. With numbers like ...

What you need to know The prevalence of heart failure across Europe is estimated to be 1-2% of adults.1 In the UK, this places a substantial burden on patients and healthcare resources, including ...

Prior authorization, a process that requires physicians to obtain approval from health care insurers before certain treatments are covered, may keep patients from filling prescriptions for two ...

Prior authorization, a process that requires physicians to obtain approval from health care insurers before certain treatments are covered, may keep patients from filling prescriptions for two ...

Background Pharmacotherapy combinations have been shown to improve survival and reduce hospitalisations in adults with ...

Add Yahoo as a preferred source to see more of our stories on Google. The Texas-based broadcaster shares her "breaking point" and reveals a medical scare that influenced her perspective on appearance ...

A secondary analysis of the SOUL trial shows significant improvement in heart failure outcomes with oral semaglutide vs placebo, consistent with the injectable formulation.

Oral semaglutide reduces risk for heart failure events among patients with T2D and preexisting heart failure, according to the SOUL trial.

After a heart attack, the heart struggles to recoup and maintain energy. One third of patients develop heart failure as a ...

A new study from researchers led by Johns Hopkins Medicine reports substantial new evidence that elevated blood biomarkers of subclinical heart injury or stress — heart muscle damage without symptoms ...

On 6 March 2026, Japan approved the world’s first iPS stem cell treatments for Parkinson’s and severe heart failure. Could ...